Simcere Pharmaceutical Group Ltd (2096)

Currency in HKD
12.31
-0.17(-1.36%)
Closed·
2096 Scorecard
Full Analysis
Management has been aggressively buying back shares
2096 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.1612.60
52 wk Range
5.0814.28
Key Statistics
Bid/Ask
12.27 / 12.31
Prev. Close
12.48
Open
12.35
Day's Range
12.16-12.6
52 wk Range
5.08-14.28
Volume
10.34M
Average Volume (3m)
20.74M
1-Year Change
127.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2096 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.64
Upside
+10.77%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Simcere Pharmaceutical Group Ltd Company Profile

Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.

Employees
6584
Market
Hong Kong

Compare 2096 to Peers and Sector

Metrics to compare
2096
Peers
Sector
Relationship
P/E Ratio
37.8x30.0x−0.5x
PEG Ratio
5.13−0.500.00
Price/Book
3.9x3.1x2.6x
Price / LTM Sales
4.2x3.5x3.3x
Upside (Analyst Target)
13.7%6.2%43.4%
Fair Value Upside
Unlock20.6%7.1%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 13.64
(+10.77% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.29%
Dividend Yield
1.42%
Industry Median 2.40%
Annualised payout
0.17
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.11 / --
Revenue / Forecast
3.52B / --
EPS Revisions
Last 90 days

2096 Income Statement

FAQ

What Stock Exchange Does Simcere Trade On?

Simcere is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Simcere?

The stock symbol for Simcere is "2096."

What Is the Simcere Market Cap?

As of today, Simcere market cap is 30.46B.

What Is Simcere's Earnings Per Share (TTM)?

The Simcere EPS (TTM) is 0.29.

From a Technical Analysis Perspective, Is 2096 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Simcere Stock Split?

Simcere has split 0 times.

How Many Employees Does Simcere Have?

Simcere has 6584 employees.

What is the current trading status of Simcere (2096)?

As of 08 Aug 2025, Simcere (2096) is trading at a price of 12.31, with a previous close of 12.48. The stock has fluctuated within a day range of 12.16 to 12.60, while its 52-week range spans from 5.08 to 14.28.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.